AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
AVNR
Delisted
AVNR was delisted on the 12th of January, 2015.
100 hedge funds and large institutions have $384M invested in AVANIR PHARMACEUTICALS, INC CL A in 2014 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 38 increasing their positions, 31 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
100
Holders Change
-1
Holders Change %
-0.99%
% of All Funds
2.89%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
38
Reduced
31
Closed
18
Calls
$31.2M
Puts
$10.2M
Net Calls
+$21.1M
Net Calls Change
+$10.4M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$12.3M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$3.09M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.65M |
| 4 |
Goldman Sachs
New York
|
+$1.72M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$1.33M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$6.32M |
| 2 |
AG
Artal Group
Luxembourg
|
-$4.04M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$3.68M |
| 4 |
Morgan Stanley
New York
|
-$2.58M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.85M |
